Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05699096

Perfluorooctyl Bromide Which Empowers the Liquid to Flat the Detached Retina and Displace the Underneath Fluids Anteriorly

Perfluorooctyl Bromideessential for Repositioning Giant Retinal Breaks and Can be Used for Removal of Subretinal Fluid as Well as Stabilization of the Retina to Offset

Status
Recruiting
Phase
Study type
Observational
Enrollment
20 (estimated)
Sponsor
EL Romany Ophthalmics Factory · Industry
Sex
All
Age
20 Years – 50 Years
Healthy volunteers
Not accepted

Summary

Perfluorohexyloctaneis Essential for Repositioning Giant Retinal Breaks and Can be Used for Removal of Subretinal Fluid as Well as Stabilization of the Retina to Offset

Conditions

Timeline

Start date
2024-09-01
Primary completion
2025-07-01
Completion
2026-07-01
First posted
2023-01-26
Last updated
2024-07-03

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05699096. Inclusion in this directory is not an endorsement.

Perfluorooctyl Bromide Which Empowers the Liquid to Flat the Detached Retina and Displace the Underneath Fluids Anterior (NCT05699096) · Clinical Trials Directory